Atypical BRAF Alterations – CMed
People with Advanced Malignancies Harboring MEK or Atypical BRAF Alterations are asked to participate in a research study being conducted by Montefiore Medical Center.
You may be eligible to participate in this study if you:
- Are a male or female at least 18 years of age
- Have a locally advanced or metastatic malignancy
- Have adequate renal, hepatic, cardiac, and bone marrow function
- Have a tumor harboring a MEK or atypical BRAF alteration
You may NOT participate in this study if you:
- Have Gastrointestinal (GI) condition that could impair absorption of study medication
- Have known uncontrolled brain metastases
- Have had major surgery within 4 weeks prior to first dose.
- Have received any cancer-directed therapy
- Have any evidence of serious active infections
- Are pregnant or breastfeeding
Contact Information
Mohammad Ghalib, Study Coordinator
1695 Eastchester Road, 2nd floor
Bronx, NY 10461
Phone: (718) 405-8515
Email: mhghalib@montefiore.org